| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/26/2006 | EP1244451B1 Substituted piperazine and piperidine calcium channel blockers |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP0985028B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 07/26/2006 | CN2798942Y Aspirin dipyridamole slow-release tablet |
| 07/26/2006 | CN1809632A Perivascular mesenchymal precursor cells |
| 07/26/2006 | CN1809581A Alkylamino alkoxyl substituted C-glycosylisoflavones and preparing method and the use of the same |
| 07/26/2006 | CN1809541A Aniline derivatives |
| 07/26/2006 | CN1809353A Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1809345A Enalapril-nitroxyderivatives derivatives and related compounds as ACE inhibitors for the treatment of cardiovascular diseases |
| 07/26/2006 | CN1809284A Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress |
| 07/26/2006 | CN1807435A Water soluble phosphate ester salt ofú¿Zú®-3'-hydroxy-3,4',5-trimethoxydiphenyl ethylene, and its preparation method ,pharmaceutical composition and uses |
| 07/26/2006 | CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 07/26/2006 | CN1807417A Novel waterless crystallization-free rosuvastatin calcium |
| 07/26/2006 | CN1807391A Carboxyl substituted resveratrol analog compound and its preparation method |
| 07/26/2006 | CN1806846A Chinese medicinal composition, its preparation process and quality control method |
| 07/26/2006 | CN1806838A Chinese medicinal liquor |
| 07/26/2006 | CN1806835A Pharmaceutical composition for treating cerebral hemorrhage and its preparation method |
| 07/26/2006 | CN1806830A Chinese medicinal composition, its preparation process and quality control method |
| 07/26/2006 | CN1806819A Quality control method for red sage root and notoginseng preparation |
| 07/26/2006 | CN1806813A Orally quick-acting tablet of ginseng stem leaf saponin including orally disintegrating tablet and dispersible tablet and method for preparing the same |
| 07/26/2006 | CN1806812A Preparation method of gingko leaf soft capsule |
| 07/26/2006 | CN1806808A Breviscapine orally disintegrating tablet and preparation method thereof |
| 07/26/2006 | CN1806804A Irbesartan and hydrochlorthiazide chewing tablet and preparation method thereof |
| 07/26/2006 | CN1806799A Medicinal composition of tanshinone IIA sulfate and ferulic acid and preparation method thereof |
| 07/26/2006 | CN1806795A Breviscapine and borneol constituted composite injection formulation and preparation method thereof |
| 07/26/2006 | CN1806646A Lily tea with health-preserving function |
| 07/26/2006 | CN1266150C 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 07/26/2006 | CN1266136C Kinetic resolution of intermediate for preparing benazepril and its analogues |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1266129C New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them |
| 07/26/2006 | CN1266126C Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/26/2006 | CN1265829C Healthy product for preventing and treating cardiovascular and cerebrovascular disease |
| 07/26/2006 | CN1265828C Chinese medicine preparation for treating coronary heart disease and angina pectoris and its preparation method |
| 07/26/2006 | CN1265819C Plaster for treating haemorrhoids |
| 07/26/2006 | CN1265816C Lotion for curing hemorrhoid |
| 07/26/2006 | CN1265811C Ginseng and aconite freeze dried powder for treating qi vacuity and yang depletion |
| 07/26/2006 | CN1265807C Flavonoid extract product containing pedaliin and application |
| 07/26/2006 | CN1265802C Effective extract of Chinese silkuine bark with cardotonic function and its preparing process |
| 07/26/2006 | CN1265788C Medicinal compositions |
| 07/26/2006 | CN1265785C Chrono-slow-releasing preparation of hydrochloride verapamil |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081469 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081261 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health |
| 07/25/2006 | CA2369095C Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 07/25/2006 | CA2186245C Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 07/20/2006 | WO2006076595A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/20/2006 | WO2006076097A2 Stable non-crystalline formulation comprising losartan |
| 07/20/2006 | WO2006075642A1 Hypoxia response enhancing agent |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006075587A1 Csf-containing remedy to be administered in low dose |
| 07/20/2006 | WO2006075523A1 Blood cholesterol reducing oral composition |
| 07/20/2006 | WO2006075509A1 Endotoxin activity inhibitor |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074924A1 3,4,(5)-substituted tetrahvdropyridines |
| 07/20/2006 | WO2006074918A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/20/2006 | WO2006074897A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | WO2006074872A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | WO2006074813A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
| 07/20/2006 | WO2006074802A1 Use of a trpc channel for the treatment of a cardiovascular disease |
| 07/20/2006 | WO2006036871A3 Plant pr-5 proteins as mammalian therapeutic agents |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160848 Method of controlling damage mediated by alpha, beta-unsaturated aldehydes |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160810 2-Alkoxyphenyl substituted imidazotriazinones |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160730 Administering pro-adrenomedullin N-terminal 20 peptide to induce neovascularization; use in treating coronary artery disease, peripheral vascular disease, and wounds; skin and organ (including heart) grafts |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060160083 Diagnositics and therapeutics for diseases associated with human g-protein couple receptor 14 (gpr14) |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159719 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/20/2006 | US20060159711 Therapeutic agent for hemorrhoidal disease |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | DE102005001989A1 Intravenöse Formulierungen von PDE-Inhibitoren Intravenous formulations of PDE inhibitors |
| 07/20/2006 | CA2594775A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/20/2006 | CA2594709A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | CA2594484A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | CA2594419A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
| 07/20/2006 | CA2593603A1 Use of a trpc channel for the treatment of a cardiovascular disease |
| 07/20/2006 | CA2593268A1 Macrocyclic compounds useful as bace inhibitors |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | CA2590898A1 3,4,(5)-substituted tetrahvdropyridines |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |